# A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

> **NCT03988088** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 18 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Lasmiditan

## Key facts

- **NCT ID:** NCT03988088
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2020-01-19
- **Final completion:** 2020-02-24
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03988088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03988088, "A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03988088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*